AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Psychiatrictimes

Published November 4, 2026

Brain Trust: Bessel van der Kolk, MD, on Complex PTSD, Attachment, and the Limits of ...

Read the full story at Psychiatrictimes

Explore why meds fall short for complex trauma—and how EMDR, body-based therapies, and psychedelic -assisted treatment reshape healing, safety,.

Post on X

Share this story

Surfaced by 2 Google Alerts

Psychedelics
MDMA